Table 1.

Baseline Clinical and Demographic Charateristics

Characteristics	Number of Patients (% of total)
Number of Enrolled Patients	26
Median Age (age range)	37 years (range 27 to 40)
Age <35	8 (36%)
Age >35	14 (64%)
Race
Caucasian	4 (15%)
African-American	13 (50%)
Hispanic	9 (35%)
Chemotherapy Regimen*
ACT	24 (93%)
CMF	1 (4%)
CAF	1 (4%)
Adjuvant Hormone Therapy
Tamoxifen	14 (54%)
Aromatase inhibitor	3 (11%)
None	9 (35%)
Menstrual status at 52 weeks
Amenorrhea	11 (42%)
Menstruating	15 58%)

^*A=doxorubicin; C=cyclophosphamide; M=methotrexate; T-=paclitaxel; F=5-FU